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A B S T R A C T
Chronic Q fever caused by Coxiella burnetii is uncommon in the United States and is most often associated
with infective endocarditis. We present a 52-year-old woman with a history of aortic valve replacement
and rheumatoid arthritis treated with Etanercept with chronic Q fever manifesting as prosthetic valve
infective endocarditis. Explanted valve tissue showed organisms conﬁrmed to be C. burnetii by PCR
(polymerase chain reaction) sequencing. She subsequently reported consumption of unpasteurized cow
milk which was the likely source of C. burnetii. She continues to do well 6 months after valve replacement
on oral doxycycline and hydroxychloroquine.
 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Q fever is caused by the small gram-negative intracellular
bacterium, Coxiella burnetii. It is rare and there are approximately
40 cases reported annually in the United States [1]. Chronic Q fever is
also rare, occurring in <5% of persons with acute infection and most
commonly occurs as infective endocarditis (IE) or vascular infection.
We present a 52-year-old woman from Michigan with chronic Q
fever presenting as prosthetic aortic valve infective endocarditis.
PCR testing for bacterial organisms performed on the explanted
cardiac valve tissue conﬁrmed the diagnosis of C. burnetii IE
[2]. Subsequent history identiﬁed consumption of raw milk from a
shared cow in a local farm as the likely source of the pathogen.
Clinical history
A 52-year-old Caucasian woman, who is an educator from
Kalamazoo, Michigan, was referred to the Cleveland Clinic with a
chief complaint of fever, chills, and progressive dyspnea on
exertion of several months duration. Her fever, chills, and night
sweats were more prominent in the last two weeks prior to* Corresponding author at: 9500 Euclid Avenue, Mailstop G21, Cleveland, OH
44195, United States. Tel.: +1 216 444 8976.
E-mail address: gordons@ccf.org (S.M. Gordon).
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increased markedly in the last one month associated with nausea
and non-bloody, non-bilious vomiting with reduced oral intake
and involuntary weight loss of 25 pounds over this period. She has
rheumatoid arthritis (RA) and has been taking Etanercept for the
last 15 years. She underwent an aortic valve replacement due to
aortic regurgitation 12 years prior to presentation at our
institution. She denied exposure to sick contacts, invasive dental
procedures, intravenous drug use, tick bites or recent travel. She
has an indoor pet cat.
On examination, she appeared alert and well-oriented but was
weak and fatigued. She had a blood pressure of 104/57 mmHg and
was tachycardic with a pulse rate of 135 bpm. On cardiovascular
exam, there was a 3/6 diastolic murmur appreciated in the left
sternal area with the presence of normal S1 and S2. There was a
well-healed median sternotomy scar from her prior open heart
surgery. On abdominal examination, the spleen was palpable at
23 cm from the costal margin with tenderness to deep palpation in
the left upper quadrant.
During the course of admission, laboratory tests showed a
normocytic normochromic anemia with hemoglobin of 8.4 g/dL
(reference range 12.1–15.1 g/dL) and a normal white blood cell
count of 6.81 k/ml (reference range 4.5–11.0 k/ml). Her spleno-
megaly was initially thought to be neoplastic or rheumatologic in
etiology and thus she was referred for a bone marrow biopsy.
Pathologic review of her bone marrow specimen revealed ander the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
Serum serologies detecting phase 1 and phase 2 antibodies to Coxeilla antigen.
IgG IgM IgA
On admission: (reference <1:16)
Phase 1 1:1024 1:64 >1:1024
Phase 2 1:1024 1:256 <1:16
After 2 months of treatment: (reference <1:16)
Phase 1 1:1024 1:1024 <1:16
Phase 2 1:1024 1:1024 <1:16
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were identiﬁed. A single blood culture (one of the four) was
positive for growth of coagulase-negative Staphylococcus. This
result prompted a transthoracic echocardiogram (TTE) which was
followed by a transesophageal echocardiogram (TEE) given high
clinical suspicion for IE. These tests showed moderate (2–3+)
prosthetic aortic regurgitation and an aortic root abscess. She was
started empirically on vancomycin and ceftriaxone and was
scheduled for open heart surgery. The patient underwent aortic
valve and root replacement with a 22-mm aortic homograft on day
3 of admission. Pathologic examination of the surgical specimen
showed abundant ﬁbrinous exudate with mild inﬂammation,
mostly macrophages. A Gomori’s methenamine silver stain
demonstrated intracellular and extracellular small coccobacillary
organisms (Fig. 1), but no microorganisms were apparent on the
Gram and Periodic acid-Schiff stain. 16S rDNA sequencing of the
valves came back positive for C. burnetii on post-operative day
10. Further retrospective history taking from the patient revealed
that she had imbibed unpasteurized cow milk two years previously
for a period of 2 months via cow sharing at a local farm in Michigan.
C. burnetii titers were consistent with chronic Q fever (high titers to
IgG phase 1 titers) (Table 1). She was treated with oral doxycycline
(100 mg orally twice daily) and hydroxychloroquine (200 mg three
times daily) after checking for glucose-6-phosphate dehydroge-
nase deﬁciency. At six months follow up, she has recovered with
normal ophthalmologic evaluations (to assess for retinal toxicity)
with plans to complete 18 months of treatment.
Discussion
Q fever is a zoonotic rickettsiosis caused by C. burnetii that is
uncommon in the United States with approximately 40 cases
reported annually [1]. It presents as an either acute or chronic
infection and is manifested as a nonspeciﬁc ﬂu-like illness in most
patients. Acute infection produces a pneumonia or infectious
hepatitis syndrome in its more severe form. Less than 5% of
patients with documented acute infection develop chronic
infection [3]. The chronic form of infection presents as an
endovascular infection causing endocarditis, mycotic aneurysm,Fig. 1. Histology of the aortic valve. (A) High power magniﬁcation of the hematoxylin-eos
ﬁbrinous background (original magniﬁcation 600). (B) Small coccobacillary forms, mos
and highly suggestive of bacterial organisms, were observed in the Gomori methenamor infected vascular graft [3]. 1–5% of acute Q fever and up to
60–80% of chronic cases can develop endocarditis [4]. Chronic Q
fever is uniformly fatal if not treated.
The largest documented outbreak of Q fever occurred in the
Netherlands from 2007 to 2010 where more than 4000 cases were
identiﬁed. The etiology of this outbreak was felt to be increased
contact between goat farms and high-population density areas
[5]. Aerosol transmission of bacteria from parturient animals and
contact with bodily ﬂuids of infected animals are the primary
modes of transmission. Oral consumption of raw milk is
considered a risk factor for transmission, but until recently was
felt to play a minor role [3]. Raw milk consumption has been
associated with seroconversion but there was insufﬁcient evidence
of it causing clinical infection [6]. Coxiella spores are extremely
infectious and resistant to heat which emphasizes the need for
pasteurization to effectively kill this species in milk products.
Pasteurization for 30 min at 63 8C (145 8F) or 15 s at 72 8C (161 8F)
can lead to eight decimal reductions in the number of Coxiella
spores [6]. A recent outbreak in Michigan, where 5 cases were
detected over a three month period in 2011, has been reported
where the only predisposing condition common to all infections
was consumption of unpasteurized milk [7]. Such consumption is
common in farm workers, cow share owners, or those buying milk
from bulk tanks.
In a French study of 92 patients with chronic Q fever between
1982 and 1990, the risk factors for infection include immunosup-
pression (20.2%), preexisting heart or vascular conditions (88.4%)
and preexisting valvulopathy (88%) [4]. Prosthetic valves arein stained section showed basophilic material within degenerated macrophages in a
tly following the contours of macrophages consistent with intracellular localization
ine silver stain (original magniﬁcation 600).
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factors for acquiring endocarditis amongst the chronic Q fever
patients [8]. Studies show that there is equal involvement of both
aortic and mitral valves [4].
Tumor necrosis factor (TNF) plays an important role in the
immune response against this pathogen [9]. Experiments using an
animal model consisting of knockout mice found that there was
severe and fatal chronic Q fever in severe combined immunodeﬁ-
ciency (SCID) mice. Florid multiplication of viable microorgan-
isms has been noted within the macrophages of infected mice
[10]. The artiﬁcial immunosuppression of mice in these studies
have led to postulation that administration of TNF blockers may
put patients at greater risk for chronic Q fever. The literature
regarding Q fever and biologics is sparse. One case has been
reported of a RA patient on Etanercept who did not have any acute
phase of illness and was diagnosed after valve cultures obtained at
the time of open heart surgery came back positive [11]. Our
patient was on Etanercept for approximately 15 years. Given its
mechanism of TNFa inhibition, cytokine production by the
macrophages and lymphocytes is decreased [9]. Since RA patients
on immunotherapy are considered at increased risk of chronic
infection, they need to be carefully monitored and counseled
about decreasing risk of exposure [12].
The main symptoms of Q fever endocarditis are fever, fatigue,
weight loss, night sweats, and hepatosplenomegaly [3]. A study
from France which included 92 patients with chronic Q fever
revealed anemia (60% of cases), increased erythrocyte sedimenta-
tion rate (100% of cases), and thrombocytopenia (50% of cases).
Liver enzymes may also be elevated [4]. Blood cultures are
typically negative given the special methods of culture required for
isolation. Echocardiography shows cardiac vegetations only in 12%
of cases [4].
C. burnetii demonstrates a unique characteristic called phase
variation [5]. Phase 1 is the virulent form with phase 2 being the
avirulent form which is demonstrated by serial passage in cell
culture or embryonated hen eggs. Only phase 1 organisms affect
humans but antibodies are formed for both phases which are
detected using serology. Phase variation occurs due to the presence
of lipopolysaccharide. Development of antibodies only occurs to
the phase 2 antigen in the acute form of infection [13].
Chronic Q fever is established if infection persists for more than
6 months and there is a presence of IgG and IgA to phase 1 and
phase 2 antigens. The presence of IgG phase 1 titer >1:800 along
with IgA phase 1 titer of >1:25 is considered for the diagnosis of
chronic disease [5]. However there have been reports of inade-
quate serologic response in chronic Q fever cases [14]. Studies have
shown the overlap in both acute and chronic form serologic titers.
Hence the use of serologic titers in distinguishing the stage of
disease or outcome is problematic. They are also not a useful tool
for deciding the duration of treatment [15]. Shortcomings of
serologic testing and culture as well as prolonged turn around
times for these tests highlights the potential beneﬁt of PCR on
pathologic specimens [2,5]. Histologic examinations of infected
cardiac valves show calciﬁcation, ﬁbrosis, and typically pauci-
inﬂammatory changes with very small or absent vegetations [16].
The usual medical treatment of chronic Q fever is doxycycline
and hydroxychloroquine for a period of 24 and 18 months in casesof prosthetic valve and native valve endocarditis, respectively [8].
C. burnetii needs an acidic pH to replicate inside the cellular
phagolysosomes. Hydroxychloroquine is lysosomotropic which
increases the pH of the phagolysosomes, thus decreasing bacterial
replication. Doxycycline is bactericidal in its activity and when
combined with hydroxychloroquine is very effective. Cotrimox-
azole is an alternative used in pregnancy and for children below
8 years of age. Rifampicin, Quinolones and Macrolides are not as
effective and there is limited evidence for their usage as alternative
regimens [17]. Cardiac surgery is usually recommended in cases of
heart failure or valvular abscesses. Reports exist of cases with
clinical and serological cure without adjunctive surgical treatment
[3,8]. Treatment and serologic follow-up are controversial with
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